Slávka Čarnická

501 total citations
27 papers, 437 citations indexed

About

Slávka Čarnická is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Slávka Čarnická has authored 27 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 15 papers in Molecular Biology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Slávka Čarnická's work include Cardiac Ischemia and Reperfusion (22 papers), Anesthesia and Neurotoxicity Research (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Slávka Čarnická is often cited by papers focused on Cardiac Ischemia and Reperfusion (22 papers), Anesthesia and Neurotoxicity Research (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Slávka Čarnická collaborates with scholars based in Slovakia, Greece and Czechia. Slávka Čarnická's co-authors include T Ravíngerová, Adriana Adameová, D Pancza, Adrián Szobi, Antigone Lazou, Eleftheria Galatou, Monika Barteková, Vinoth Kumar Megraj Khandelwal, František Kolář and Miroslav Ferko and has published in prestigious journals such as Cardiovascular Research, European Journal of Pharmacology and Current Pharmaceutical Design.

In The Last Decade

Slávka Čarnická

27 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slávka Čarnická Slovakia 15 231 220 165 82 57 27 437
Nilguen Gedik Germany 5 234 1.0× 115 0.5× 158 1.0× 107 1.3× 93 1.6× 6 408
Judit Pipis Hungary 11 146 0.6× 112 0.5× 111 0.7× 59 0.7× 47 0.8× 18 328
Gabriella F. Kocsis Hungary 13 243 1.1× 185 0.8× 141 0.9× 100 1.2× 85 1.5× 17 526
Kirsten M. Smeele Netherlands 8 174 0.8× 187 0.8× 64 0.4× 58 0.7× 70 1.2× 9 346
Rianne Nederlof Netherlands 13 165 0.7× 287 1.3× 127 0.8× 54 0.7× 41 0.7× 25 532
Nicolaj Brejnholt Støttrup Denmark 7 193 0.8× 92 0.4× 78 0.5× 115 1.4× 84 1.5× 12 335
Tsai‐Fwu Chou Taiwan 11 228 1.0× 143 0.7× 214 1.3× 102 1.2× 71 1.2× 16 531
Daisuke Sunaga Japan 9 113 0.5× 147 0.7× 109 0.7× 45 0.5× 27 0.5× 18 353
Jacob Johnsen Denmark 11 208 0.9× 102 0.5× 94 0.6× 113 1.4× 98 1.7× 18 366
Astrid Buechert Germany 3 395 1.7× 265 1.2× 168 1.0× 203 2.5× 143 2.5× 4 591

Countries citing papers authored by Slávka Čarnická

Since Specialization
Citations

This map shows the geographic impact of Slávka Čarnická's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slávka Čarnická with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slávka Čarnická more than expected).

Fields of papers citing papers by Slávka Čarnická

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slávka Čarnická. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slávka Čarnická. The network helps show where Slávka Čarnická may publish in the future.

Co-authorship network of co-authors of Slávka Čarnická

This figure shows the co-authorship network connecting the top 25 collaborators of Slávka Čarnická. A scholar is included among the top collaborators of Slávka Čarnická based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slávka Čarnická. Slávka Čarnická is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szobi, Adrián, et al.. (2018). Cardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane. Journal of Cellular and Molecular Medicine. 22(9). 4183–4196. 32 indexed citations
2.
Čarnická, Slávka, Adrián Szobi, Zoltán Giricz, et al.. (2016). Data on necrotic and apoptotic cell death in acute myocardial ischemia/reperfusion injury: the effects of CaMKII and angiotensin AT1 receptor inhibition. Data in Brief. 7. 730–734. 3 indexed citations
3.
Szobi, Adrián, Slávka Čarnická, D Pancza, et al.. (2016). Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?. Current Pharmaceutical Design. 22(42). 6451–6458. 5 indexed citations
4.
Ravíngerová, T, et al.. (2016). Remote Preconditioning as a Novel „Conditioning“ Approach to Repair the Broken Heart: Potential Mechanisms and Clinical Applications. Physiological Research. 65 Suppl 1. S55–S64. 14 indexed citations
5.
Čarnická, Slávka, Adrián Szobi, Zoltán Giricz, et al.. (2015). Oxidative activation of CaMKIIδ in acute myocardial ischemia/reperfusion injury: A role of angiotensin AT1 receptor-NOX2 signaling axis. European Journal of Pharmacology. 771. 114–122. 16 indexed citations
6.
Ferko, Miroslav, Iveta Waczulı́ková, Slávka Čarnická, et al.. (2015). Participation of Heart Mitochondria in Myocardial Protection Against Ischemia/Reperfusion Injury: Benefit Effects of Short-Term Adaptation Processes. Physiological Research. 64(Suppl 5). S617–S625. 5 indexed citations
8.
Ferko, Miroslav, Slávka Čarnická, Iveta Waczulı́ková, et al.. (2014). Remote Ischemic Preconditioning of the Heart: Protective Responses in Functional and Biophysical Properties of Cardiac Mitochondria. Physiological Research. 63(Suppl 4). S469–S478. 19 indexed citations
9.
Čarnická, Slávka, Zuzana Sumbalová, O Uličná, et al.. (2014). P406Adaptive changes of rat heart mitochondrial respiration: response of remote ischemic preconditioning. Cardiovascular Research. 103(suppl 1). S74.6–S75. 3 indexed citations
11.
Szobi, Adrián, et al.. (2013). Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: effects on programmed necrotic and apoptotic cell death. Molecular and Cellular Biochemistry. 388(1-2). 269–276. 43 indexed citations
12.
Ravíngerová, T, Slávka Čarnická, Eleftheria Galatou, et al.. (2013). Upregulation of Genes Involved in Cardiac Metabolism Enhances Myocardial Resistance to Ischemia/Reperfusion in the Rat Heart. Physiological Research. 62(Suppl 1). S151–S163. 17 indexed citations
13.
Ravíngerová, T, et al.. (2012). The Impact of Lifestyle-Related Risk Factors on Cardiac Response to Ischemia and Possibilities to Restore Impaired Ischemic Tolerance. Physiological Research. 61(Suppl 2). S1–S10. 11 indexed citations
14.
Čarnická, Slávka, Adrián Szobi, Marek Máťuš, et al.. (2012). Pleiotropic Effects of Simvastatin Are Associated With Mitigation of Apoptotic Component of Cell Death Upon Lethal Myocardial Reperfusion-Induced Injury. Physiological Research. 61(Suppl 2). S33–S41. 17 indexed citations
16.
Ravíngerová, T, Slávka Čarnická, Adriana Adameová, et al.. (2012). PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia–reperfusion injury: involvement of PI3K–Akt. Canadian Journal of Physiology and Pharmacology. 90(8). 1135–1144. 47 indexed citations
18.
Ravíngerová, T, et al.. (2011). The role of PPAR in myocardial response to ischemia in normal and diseased heart. General Physiology and Biophysics. 30(4). 329–341. 25 indexed citations
19.
Adameová, Adriana, D Pancza, M Kuželová, et al.. (2009). Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Physiological Research. 58(3). 449–454. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026